Patent · US Active

Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators

US9079911B2 · kind B2 · utility

8Cited by

0References

17Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Wenying Chai · San Diego, US
Michael A. Letavic · San Diego, US
Kiev S. Ly · San Diego, US
Daniel J. Pippel · Del Mar, US
Dale A. Rudolph · San Diego, US
Kathleen C. Sappey · San Diego, US
Brad M. Savall · San Diego, US
Chandravadan R. Shah · San Diego, US
Brock T. Shireman · Poway, US
Akinola Soyode Johnson · San Diego, US
Emily M. Stocking · Encinitas, US
Devin M. Swanson · Carlsbad, US

Key dates

Filing date	Dec 23, 2013
Grant date	Jul 14, 2015
Priority date	—
Expiry date	Dec 23, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.